Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Immunotherapy of cancer

PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in NSCLC

Date

24 Nov 2019

Session

Mini Oral session - Immunotherapy of cancer

Topics

Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Jiaqing Liu

Citation

Annals of Oncology (2019) 30 (suppl_9): ix107-ix114. 10.1093/annonc/mdz438

Authors

J. Liu, H. Zhou, Y. Zhang, Y. Huang, Y. Yang, W. Fang, L. Zhang

Author affiliations

  • Department Of Medical Oncology, Sun Yat-sen University Cancer Center, 510060 - Guangzhou/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.